Original contributionCorrelation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer☆,☆☆
Introduction
Recently, histologic subtypes of gastric cancer associated with a distinctive prognosis have been identified as a result of extensive reinvestigation of histopathologic patterns, clinicopathologic correlations, and patient survival. Muconodular expansile, very well differentiated tubular, low-grade desmoplastic, and high lymphoid (mainly of CD8-positive T cells) response (HLR) cancer subtypes were among those associated with more favorable survival, whereas diffuse anaplastic, poorly differentiated (neuro)endocrine or massively invasive mucinous cancer and a variety of rare neoplasms such as hepatoid, choriocarcinomatous, or adenosquamous carcinoma were associated with worse outcome, compared with ordinary cohesive (so called “intestinal”) or diffuse cancers [1], [2], [3], [4], [5]. Based on these prognostically informative subtypes, a comprehensive 3-grade classification of all gastric cancers was developed, which proved to be highly predictive of patient survival [6]. In addition, molecular analysis of the same series showed a correlation between high microsatellite DNA instability (MSI-H) and improved survival, when coexisting with HLR. On the other hand, a poor prognosis had been predicted by other genomic lesions, as, for instance, specific p53 mutations [6]. However, scarce information is available on genome-wide molecular analysis of prognostically informative histologic subtypes, because most of the studies published so far are based on broad tumor categories like intestinal and diffuse histotypes [7], [8], [9], [10], [11], [12] or histologically more descriptive types [13], [14], which are themselves of limited prognostic value [15], [16], rather than on histologic types specifically designed to predict patient outcome [1], [2], [3], [4], [5], [6].
In this study, a sample of 81 invasive (from T1b, deep submucosa, to T4 and stages I to IV) gastric cancers, representing the main histologic types and subtypes, were selected from a larger series of cases that had already undergone histologic, histochemical, and molecular investigation (4-6). High-resolution genome-wide array comparative genomic hybridization (aCGH) procedures were applied to DNA extracted from tumor tissue sections and the number and severity of DNA copy number aberrations (CNAs) were compared with histotypes, their proposed malignancy grades, and actual patient survival.
Section snippets
Materials and methods
Eighty-one gastric cancers were selected from 294 invasive gastric cancers, representing all the main histotypes and stages of the disease that had undergone surgery at the San Matteo General Hospital from 1984 to 2000 and followed for a median of 150 months. The extensively sampled neoplasms were classified histologically as detailed elsewhere [5], [6] on paraffin sections stained with hematoxylin-eosin, Periodic acid–Schiff stain–Alcian blue, and immunohistochemical tests for mucins (MUC1,
Results
Of the 81 gastric cancers tested, 19 cases failed to meet the specific standards of DNA quality required to be included in aCGH experiments, whereas in a further 7 cases, the poor quality of the results obtained in these experiments prevented any useful analysis. Among the 55 tumors analyzed successfully, 6 cases of diffuse (5 low-grade, 4 of which desmoplastic and 1 muconodular, and 1 non–low-grade desmoplastic) histologic type with a proportion of neoplastic cells in the 50% to 75% range
Discussion
This study revealed a substantial correlation between the severity of genomic alterations, histologic grade, and patient survival in invasive gastric cancer. These findings, besides confirming previous observations concerning the influence of amplifications on survival in gastric cancer [8] and the number and length of genomic alterations on prognosis in colorectal cancer [25], provide a genetic background for the grading system recently developed for gastric cancer based on the predictive role
References (29)
- et al.
Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach
Hum Pathol
(1999) - et al.
ECL cell tumour and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis
Gastroenterology
(1999) - et al.
Lymphocyte-rich gastric cancers: associations with Epstein-Barr virus, microsatellite instability, histology, and survival
Mod Pathol
(2003) - et al.
Lower- and higher-grade subtypes of diffuse gastric cancer
Hum Pathol
(2009) - et al.
DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization
Cancer Genetics Cytogenetics
(2006) - et al.
Nonrandom chromosomal numerical abnormality predicting prognosis of gastric cancer: a retrospective study of 51 cases using pathology archives
Lab Invest
(2003) - et al.
Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression
Mod Pathol
(2004) - et al.
Are carcinomas of the cardia oesophageal or gastric adenocarcinomas?
Eur J Cancer
(2003) - et al.
Identification of a lower grade muconodular subtype of gastric mucinous cancer
Virchows Arch
(2004) - et al.
A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis
Virchows Arch
(2009)
Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer
Genes Chromosomes Cancer
Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival
Cellular Oncology
Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization
Genes Cromosomes Cancer
Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer
J Pathol
Cited by (22)
Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization
2017, Human PathologyCitation Excerpt :Amplified genes encoding receptor tyrosine kinases (RTKs) such as ERBB2, EGFR, FGFR2, and MET are established or potential targets of molecular therapy in advanced gastric cancers. In addition to RTK genes, recent comprehensive genomic analyses of copy number alterations using a high-resolution single-nucleotide polymorphism array (SNP) [7], along with oligonucleotide array comparative genomic hybridization [8], have shown that the genes encoding cyclin E (CCNE1), cyclin D1 (CCND1), and CDK6 (CDK6) are frequently amplified in gastric cancer. Coamplification of CCNE1 or CCND1 with ERBB2 reportedly reduces the antitumor effects of trastuzumab, a monoclonal antibody against ERBB2, in gastric and breast cancers [9].
Molecular classification of gastric cancer
2016, Annals of OncologyCitation Excerpt :The GC incidence rate in Western Europe (∼19%) is higher than that in South Africa (SA) (∼10%) despite elevated frequencies of H. pylori infection in the latter [52]. Microsatellite instable (MSI) GCs have been reported to display fewer chromosome aberrations than microsatellite stable (MSS) cancers [53]. A comparison of MSI profiles between UK and SA GC patients revealed that ∼3% of UK patients showed MSI compared with ∼24% of SA patients, whereas the analysis of DNA copy number profiles showed that UK patients displayed greater rates of chromosome gain/loss (∼27%) compared with SA patients (∼16%).
Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization
2014, Human PathologyCitation Excerpt :As the target of therapy with trastuzumab, the evident difference between gastric cancer and breast cancer is the intratumoral heterogeneity of ERBB2 amplification [7]. It is noteworthy that recent comprehensive genomic analyses of copy number alterations with a high-resolution single nucleotide polymorphism array [14] and oligonucleotide array comparative genomic hybridization [15] revealed that genes encoding receptor tyrosine kinases (RTKs) such as ERBB2, FGFR2, MET, and EGFR, in addition to MYC, CCND1, and MDM2, were frequently amplified in gastric cancers. It is most likely that intratumoral heterogeneity of ERBB2 amplification is based on common chromosomal instability where new amplification of some of these genes begets new cancer cells in which ERBB2 amplification is dispensable, or coamplification of new genes with ERBB2 gives sister cancer cells additional or synergistic growth advantages [16].
Histotype-based prognostic classification of gastric cancer
2012, World Journal of GastroenterologyCDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme
2021, Clinical and Translational Oncology
- ☆
The investigation was supported in part by grants from the Italian Ministry of Health (RF-PSM-2006-401346), Rome, and the University of Pavia, Pavia, Italy.
- ☆☆
The authors declare no conflict of interest.